Drug Profile
Insulin lispro biosimilar - Biocon/Viatris
Latest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Biocon
- Class Antihyperglycaemics; Insulins; Pancreatic hormones
- Mechanism of Action Ornithine decarboxylase stimulants; Phosphokinase stimulants; Protein tyrosine kinase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Type 1 diabetes mellitus; Type 2 diabetes mellitus
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Type-1 diabetes mellitus in India (SC)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Type-2-diabetes-mellitus in India (SC)